Dr. MedLaw explains the importance of discussing risks, benefits, and alternatives in a manner the patient fully understands ...

Allow Student Health Services to provide health care to a student who is under 18 years of age. This form must be completed if the student is under 18 years of age when they arrive on campus or at the ...

Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab ...

Other than the adjuvant melanoma study, other late-stage trials in BMS' current pipeline listing that mention the LAG-3 inhibitor include RELATIVITY-1093 in first-line non-small cell lung cancer ...

Provide information about a student’s past immunization for meningitis, or confirm that the student will not be immunized. If student is a minor, you can also use this form to provide consent for ...

Patients with high-risk pathological features either after neoadjuvant chemotherapy or who are cisplatin-ineligible undergo centralized ctDNA testing post-surgery. ctDNA-positive patients are ...